Product Description: Cepeginterferon alfa-2b is a pegylated interferon. And Cepeginterferon alfa-2b has PEG with molecular weight of 20 kDa as a pegylated base. Cepeginterferon alfa-2b can be used for research of various diseases, such as hepatitis C virus (HCV), polycythemia vera (PV) and essential thrombocythemia (ET)[1][2].
Applications: COVID-19-anti-virus
Formula: N/A
References: [1]Melikyan AL, et al. Cepeginterferon alfa-2b in the treatment of chronic myeloproliferative diseases. Ter Arkh. 2018 Aug 17;90(7):23-29. /[2]Znoyko OO, et al. Vozmozhnosti primeneniia tsepeginterferona al'fa-2b v sostave dvukh- (tsepeginterferon al'fa-2b i ribavirin) i trekhkomponentnoĭ (simeprevir, tsepeginterferon al'fa-2b i ribavirin) skhem protivovirusnoĭ terapii khronicheskogo gepatita S. Obzor klinicheskikh issledovaniĭ i opyta povsednevnoĭ klinicheskoĭ praktiki [Possibilities of using cepeginterferon alpha-2b in double (cepeginterferon alfa-2b and ribavirin) and triple (simeprevir, cepeginterferon alpha-2b, and ribavirin) antiviral therapy regimens for chronic hepatitis C. A review of clinical trials and experience of everyday clinical practice]. Ter Arkh. 2016;88(11):156-162. Russian.
CAS Number: 1192706-52-7
Molecular Weight: N/A
Research Area: Infection
Solubility: 10 mM in DMSO
Target: HCV;Integrin
English
Deutsch
